Get every episode summarized
Each time Lost Women of Science publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
In this first chapter of a new five-part season we meet Dr. Frances Oldham Kelsey, a physician and pharmacologist who joined the U.S. Food and Drug Administration as a medical reviewer in 1960. Before the year is out, Dr. Kelsey finds herself standing up to big pharma.
It’s September 1960 and a thick New Drug Application lands on Dr. Kelsey’s desk. The drug has already been on the market in Europe for three years and Dr. Kelsey’s supervisors expect her to rubber stamp the application. The drug is called Kevadon. Active ingredient: thalidomide. And to Frances Kelsey’s keen eye, something looks off.
Get every episode summarized
Each time Lost Women of Science publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Lost Women of Science
Profesora de química y caza criminales: La extraordinaria vida de Mary Louisa Wi...
Lost Women of Science
Best Of: Chemistry Professor and Crime Buster: The Remarkable Life of Mary Louis...
Lost Women of Science
Elizabeth Roboz Einstein: The Determined Genius Behind a Multiple Sclerosis Brea...
Lost Women of Science
Conversation: If I Am Right, and I Know I Am: Inge Lehmann, the Woman Who Discov...
Lost Women of Science